Glenmark Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Anurag Mantri as Executive Director and Global Chief Financial Officer of the company w.e.f. May 27, 2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has appointed Mr. Anurag Mantri as the Executive Director and Global Chief Financial Officer (CFO) of the company. The appointment is effective from May 27, 2025. As Global CFO, he will oversee the financial strategy and operations of the company. The company has informed the stock exchange about this key managerial appointment. No further details on his previous role or compensation were provided in this filing.
A new CFO appointment is a key leadership change that can influence the company's financial strategy, capital allocation decisions, and investor confidence. Shareholders should watch for any subsequent disclosures regarding Mantri's background and prior experience.